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It is well established that cells synchronised at the G1–S phase are highly radiosensitive. In this study, p16-null human glioma cell lines
were induced into G1 cell cycle arrest by adenovirus-mediated p16 gene transfer, and examined for radiation-induced cell killing.
Clonogenic analysis and trypan blue extraction test showed that the p16 gene transfer enhanced radiation-induced cell killing in p16-
null glioma cell lines. TUNEL assays and pulse-field gel electrophoresis confirmed that the radiation-induced cell killing of p16-
transfected cells could be caused by a nonapoptotic mechanism. Gimsa staining demonstrated that irradiation alone or Ax-mock
infection plus irradiation results in a slight increase in the frequency of cells with abnormal nucleus, compared to unirradiated
uninfected or Ax-mock infected cells. However, Ax-hp16 or Ax-hp21 infection alone modestly increased the frequency of cells with
abnormal nucleus (especially bi- and multinucleation), and 4-Gy irradiation of Ax-hp16 or Ax-hp21 infected cells substantially
enhanced this frequency. These results suggest that there exists some unknown interaction between radiation and p16 in cytoplasm/
membranes, which decreases cytokinesis and promotes abnormal nucleation. Thus, p16 expression prevented radiation-induced
apoptosis by promoting abnormal nucleation, thereby leading to another mode of cell death.
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Human malignant gliomas diffusely invade surrounding normal
brain tissue. Surgical removal of the entire tumour is difficult, and
radiation therapy is often administered as an adjuvant in the
treatment of incompletely resected tumours. However, the clinical
effectiveness of irradiation has been limited. In almost all cases,
tumours are refractory to current treatments, and the patient dies
from brain herniation due to unrestrained growth of the tumour
(Giangaspero and Burger, 1983). The median survival time of
malignant glioma patients is less than 2 years, despite extensive
and multidisciplinary treatment.
Glioma cells have been reported to display abnormality in one
or more genes responsible for regulating cell-cycle progression.
Such genes include the well-characterised tumour suppressor
genes p53, pRb, cyclin D, p21 and p16 (Gomez-Manzano et al,
1997; Costanzi-Strauss et al, 1998; Buschges et al, 1999). p53
inhibits cell-cycle progression in response to various cellular
stresses by direct transactivation of p21, an important mediator of
cell proliferation, differentiation and senescence (el-Deiry et al,
1993; Xiong et al, 1993; Noda et al, 1994). p21 inhibits the ability of
cyclin-dependent kinases (CDKs) to phosphorylate pRb, thereby
inhibiting cell entry into the S phase. Similarly, p16 inhibits the
ability of CDK4 and CDK6 to regulate the phosphorylation status
of pRb, thereby also controlling progression into the S phase
(Nobori et al, 1994; Lukas et al, 1995). Recently, several authors
have shown that 4–52% of clinical samples of malignant glioma
and 68–87% of glioma cell lines have a homozygous deletion of the
p16 locus (He et al, 1994; Nobori et al, 1994; Schmidt et al, 1994;
Ueki et al, 1996; Hama et al, 1997). Therefore, restoration of
normal function of both p53 and p16 by gene therapy is an
attractive strategy for glioma treatment.
Adenovirus-mediated gene transfer of wild-type p16 following
irradiation has previously been shown (by clonogenic survival
assay) to enhance radiosensitivity in lung non-small-cell cancer
cells (Kawabe et al, 2000). The results of clonogenic survival assays
clearly indicate that cells synchronised at the late S and early G1
phase are the most radioresistant, whereas cells synchronized at
the M phase or at the late G1 to early S phase are the most
radiosensitive (Terasima and Tolmach, 1963; Okada, 1970). The
regulatory cascade comprising pRb, cyclin D1, CDK4/CDK6 and
p16 plays a central role in cell-cycle control, and may govern
radiosensitivity as well.
We have previously demonstrated that p16 gene transfer into
human glioma cells using an adenovirus vector constructed with
the COS-TPC method completely inhibits proliferation of the cells
via G1 arrest for over 5 days (Hama et al, 1998). This adenovirus
vector has a high transfection efficiency and provides stable, long-
term gene expression. The purpose of this study was to determine
whether adenovirus-mediated p16 gene transfer is a suitable gene
replacement therapy for human glioma.
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Cells
U251MG cells (human glioma; p16, homozygous deletion; p21,
undetectable protein expression; p53, mutated at codon 273 [CGT/
CAT Arg/His]) and D54MG cells (human glioma; p16, undetectable
protein expression; p53, wild type) were used in this study (Fueyo
et al, 1996; Gomez-Manzano et al, 1996; Hama et al, 1998; Kawada
et al, 1998). U251MG cells were obtained from the Japanese Cancer
Research Resources Bank (Tokyo, Japan). D54MG cells were
provided by Dr DT Curiel (Miller et al, 1998).
Adenovirus vectors
The p16- or p21-expressing adenovirus vectors used here were also
used in previous studies of ours (Hama et al, 1998; Yamasaki et al,
2003). In brief, replication-defective adenovirus vectors were based
on the human adenovirus type 5(Ad5) serotype. The full-length
human p16 cDNA was a gift from Dr T Nobori, and the full-length
p21 cDNA was purchased from the Meiji Institute of Health
(Nobori et al, 1994; Noda et al, 1994). Recombinant adenovirus
vectors containing the full-length human p16 gene (Ax-hp16) or
p21 gene (Ax-hp21) were generated using the COS-TPC method, as
described elsewhere (Niwa et al, 1991; Miyake et al, 1996).
Exogenic p16 or p21 gene expression after Ax-hp16 or Ax-hp21
infection has been achieved in previous studies (Hama et al, 1998;
Yamasaki et al, 2003). Control vectors consisted of recombinant
adenoviruses containing an expression cassette without any
genome (mock adenovirus vector, Ax-mock). The optimal condi-
tions of the virus infection of each cell line for adequate gene
transfer were evaluated as described elsewhere (Hama et al, 1998).
For transient infection, the culture medium was replaced 2h
after infection with the adenovirus vector; for continuous
infection, the medium was not changed until analysis. Adenovirus
expression appeared to continue for 3–5 days after transient
infection, and for over 5–7 days during continuous infection
(Hama et al, 1998). In the present study, most gene transfer was
performed using continuous infection.
Irradiation and adenovirus infection
To obtain uniform and reproducible irradiation conditions, cells
were trypsinised, counted, placed in the glass tube, and irradiated
using a
60Co source at a dose rate of 0.65Gymin
 1, as described
elsewhere (Tauchi et al, 2001). Known numbers of cells were then
replated in culture dishes and returned to the incubator. One day
after irradiation, U251MG cells were infected with adenovirus
vector at 5 multiplicity of infection (MOI), and D54MG cells were
infected at 10 MOI.
Cell survival and cell viability analysis
Cell survival was assessed using clonogenic assays in monolayer
culture, as described elsewhere (Tauchi et al, 2001). In brief, the
cells were trypsinised, counted, placed in the glass tube and
irradiated, as described above. Known numbers of cells were then
replated in 100-mm culture dishes and returned to the incubator to
allow macroscopic colony development. The surviving fractions
following a given treatment were calculated based on survival of
nonirradiated noninfected cells.
The viability of cells with or without irradiation (4Gy) was
analysed using trypan blue exclusion, as described elsewhere
(Hama et al, 1998). Each experiment was repeated at least twice.
Analysis of cell cycle by flow cytometry
Cell-cycle of U251MG cells and D54MG cells was assessed using
flow cytometry, as described elsewhere (Hama et al, 1998). In
short, these cells were plated in a 100-mm dish and infected with
Ax-hp16 or Ax-mock after irradiation. The cells were collected by
trypsinisation after 3 or 6 days of incubation, washed twice with
PBS, fixed with 75% ethanol and maintained at 41C for 48h. After
centrifugation at 1500rpm for 10min, the cells were washed with
PBS and resuspended in 1ml of lysis buffer (0.1% Triton-X 100,
0.1% RNaseA) at 41C overnight to free their nuclei. Immediately
before analysis, 1ml of 50mgml
 1 propidium iodide (PI) solution
(final concentration, 25mgml
 1) was added to the cell samples.
Propidium iodide fluorescence of individual nuclei was measured
using a FACscan (Becton Dickinson Co., Lincoln Park, NJ, USA).
Data were analysed with the ModFit LT program (Becton
Dickinson Co., Lincoln Park, NJ, USA). Each experiment was
repeated at least twice.
Detection of apoptosis
Radiation-induced apoptosis was assessed morphologically by
TUNEL assay using the In Situ Apoptosis Detection Kit (Cat.
MK500, Takara Bio Inc., Ootsu, Japan). Cells were irradiated with a
dose of 4Gy, and were infected with Ax-mock, Ax-hp16 or Ax-p21
as described above. These cells were cultured in chamber slides for
further 2 or 6 days. Then, after fixation with 4% formaldehyde,
they were stained according to the manufacturer’s instructions,
and photographs were taken under 160  magnification, using a
Nikon OPTIPHOT-2 fluorescence microscope. The apoptotic index
(AI) was defined as the percentage of TUNEL-positive cells in a
200  magnified field, and the AI values of the experimental
groups were compared. Two different people blinded to the
treatment counted the positive cells in three microscopic fields on
one slide from each specimen; there were no significant differences
between the counts they obtained. Each experiment was repeated
at least twice.
Pulse-field gel electrophoresis (PFGE)
Induction of cleavage of chromatin in U251MG cells was
determined by PFGE, as described elsewhere (Hwang et al, 2000;
Cipriani et al, 2001). In breif, U251MG cells were infected with Ax-
hp16 or Ax-mock after irradiation and collected by trypsinisation
after 5 days of incubation. Cell pellets containing 2   10
7
U251MG cells/sample were resuspended in 1000mlo fC a
2þ –
Mg
2þ-free PBS and 1000ml of 1% low-melt agarose, and solidified
at 41C for 30min. Plugs were digested for 48h at 551C in 5ml of
digestion buffer containing 100mM EDTA (pH 8.0), 0.2% sodium
deoxycholate, 1% sodium lauryl sarcosine, and 1mgml
 1 protei-
nase K. The plugs were then washed four times in washing buffer
(20mM Tris-HCl (pH 8) and 50mM EDTA), loaded into a 1.2%
agarose gel, and run in 0.5x TBE buffer for 22h using the CHEF-
DR II electrophoresis cell (Bio-Rad, Hercules, CA, USA). Running
conditions were optimised to separate 50–1000-kbp DNA
fragments, as follows: temperature, 141C; switch time, 50–90s;
angle, 1201; voltage gradient, 6Vcm
 1. The standard-size DNA
ladder was included. After staining with 0.5mgml
 1 ethidium
bromide, bands were visualised using a UV transilluminator (254–
360nm).
Evaluation of nuclear morphology
Nuclear morphologic changes in U251MG or D54MG cells were
evaluated using Giemsa staining, as described elsewhere (Bhat-
tathiri et al, 1998a,b; Bhattathiri, 2001). U251MG and D54MG cells
were irradiated with a dose of 4Gy, and were infected with Ax-
mock, Ax-hp16 or Ax-p21 as described above. These cells were
cultured for a further 6 days, collected by trypsinisation, spread on
a clean glass slide, fixed in ethyl alcohol and stained with Giemsa
stain. The frequency of micronucleated, nuclear budded, binu-
cleated and multinucleated tumour cells was evaluated. The
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(Bhattathiri et al, 1998a,b; Bhattathiri, 2001). Briefly, micronu-
cleated cells contain small round bodies of nuclear material within
the cytoplasm, separate from the main nucleus (the cells indicated
with one arrow in Figure 4D and E). Nuclear budded cells have
buds adjoining the main nucleus; these could be micronuclei, if not
for the fact that their separation from the main nucleus is
indistinct (the cells indicated with two arrows in Figure 4D and E).
Binucleated cells have two nuclei. Multinucleated cells have more
than two nuclei (Figure 4C and the cells indicated with three
arrows in Figure 4E). Around 500–1000 cells were evaluated from
the samples collected on each occasion, and the results were
expressed in comparison with 1000 culture cells with a single
nucleus (ie, uninucleated cells). This experiment was repeated at
least twice.
Statistical analysis
Statistical analysis was performed by Student’s t-test using Stat
View 5.0 (Abacus Concepts, Inc). A P-value of o0.05 was
considered to indicate statistical significance.
RESULTS
Effect of p16 gene transfer on radiation-induced cell killing
We first tested whether Ax-hp16 infection increased the radio-
sensitivity of human glioma cell lines in vitro. Clonogenic assays
were performed on two glioma cell lines: U251MG (p16-null, p21-
null and p53-mutant) and D54MG (p16-null and p53-wild type).
These cell lines were infected with either Ax-hp16 or Ax-mock
after irradiation. In preliminary experiments, we compared the
effect on radiosensitivity between various time courses of
irradiation and infection (transient infection vs continuous
infection). The maximum effect was obtained when cells were
continuously infected with Ax-hp16 after irradiation. We also
assessed continuous adenovirus infection before irradiation;
however, this procedure required collection of cells by trypsinisa-
tion after infection, transfer of the medium plus cells and
adenovirus vectors to a glass tube, irradiation and replating of
irradiated cells on the culture dishes without exchanging the
medium (containing the adenovirus vector). This procedure was
intricate and not reproducible. Therefore, we chose to irradiate
cells prior to adenoviral infection. As continuous adenovirus
infection is particularly likely to cause direct cytotoxicity, we
assessed the cytotoxicity of the vector alone using plating
efficiency as the end point. Cytotoxicity became evident at MOI
values between 5 and 10 in U251MG cells, and between 7.5 and 15
in D54MG cells. Then, in further preliminary experiments, we used
MOI values of 5 and 10 in U251MG cells and MOI values of 7.5, 10
and 15 in D54MG cells to assess radiosensitisation (data not
shown). For U251MG, the most effective radiosensitisation was
achieved using an MOI value of 5; for D54MG, this MOI value
was 10.
As shown in Figure 1A, the survival of nonirradiated
U251MG cells was slightly reduced by Ax-hp16 infection to 83%;
at 2Gy, it was markedly reduced from 77 to 0.69%; at 4Gy, it
was reduced from 15 to 0.019%. The percent survival of
nonirradiated D54MG cells was slightly reduced by Ax-hp16
infection to 55%; at 2Gy, it was markedly reduced from 31 to
9.1%; at 4Gy, it was reduced from 8.5 to 0.67% (Figure 1B).
Ax-mock infection alone did not produce marked sensitisation
in either of the two cell lines in the range of 2–6Gy. U251MG
cells or D54MG cells infected with Ax-hp16 were significantly
more radiosensitive than noninfected or Ax-mock-infected cells.
This trend was similar to that of Ax-hp21-infected U251MG
cells (Figure 1C).
Next, we examined the cell viability of the U251MG and D54MG
cells using the trypan blue exclusion test (Figure 1D, E). Until 5
days after irradiation, there was no difference in viability between
Ax-h-p16-infected cells and Ax-mock-infected or noninfected cells.
In contrast, 7–8 days after irradiation, the viability of irradiated
Ax-hp16-infected cells gradually decreased, compared with Ax-
mock-infected, noninfected and nonirradiated cells. The viability
of nonirradiated Ax-hp16-infected U251MG cells decreased
gradually. The viability of irradiated Ax-hp16-infected U251MG
cells decreased more significantly than that of nonirradiated Ax-
hp16-infected cells (P¼0.005 on day 11, and P¼0.031 on day 13).
Thus, adenovirus-mediated p16 gene transfer enhanced the
radiosensitivity of glioma cell lines that lack p16, but contain either
wt-p53 or mut-p53.
Effect of p16 gene transfer on cell cycle of U251MG cells
after irradiation
To determine whether Ax-hp16 infection induced G1 cell-cycle
arrest in U251MG or D54MG cells, cell-cycle status was analysed
on days 3 and 6 using flow cytometry. Figure 2 shows the
histogram of cell-cycle status following irradiation and/or infection
with Ax-mock or Ax-hp16 on day 6 (the data for day 3 were almost
the same as that of day 6, and is not shown).
Nonirradiated Ax-hp16-infected U251MG and D54MG cells
showed G1 arrest during the 6 days following infection, whereas
the cell-cycle profile of Ax-mock-infected cells was the same as that
of noninfected cells. In U251MG cells, after 4-Gy irradiation, G2/M
accumulation occurred in Ax-mock-infected and noninfected cells.
G2/M accumulation was markedly decreased in Ax-hp16-infected
cells, compared with Ax-mock-infected and noninfected cells. In
D54MG cells, after 4-Gy irradiation, G1 accumulation occurred in
Ax-mock-infected and noninfected cells, and was significantly
increased in Ax-hp16-infected cells. These results demonstrate that
Ax-hp16 infection resulted in G1 arrest.
Apoptotic analysis
To determine whether the death of Ax-hp16-infected U251MG cells
after irradiation was due to apoptosis, we performed the TUNEL
assay and measured the level of apoptosis on the basis of TUNEL
positivity following various treatments 3 and 7 days after
irradiation. Figure 3A shows the percentage of TUNEL-positive
cells among U251MG cells that were noninfected, Ax-mock-
infected, Ax-hp16-infected or Ax-hp21-infected, with or without
irradiation. Irradiated cells that were noninfected or Ax-mock-
infected had a higher proportion of TUNEL-positive cells
(uninfected cells, 22.0% on day 3 and 15.1% on day 7; Ax-mock
infected cells, 10.6% on day 3 and 12.2% on day 7) than the
corresponding unirradiated cells. Irradiated cells that were Ax-
hp16- or Ax-hp21-infected had the same proportion of TUNEL-
positive cells (Ax-hp16-infected cells, 2.1% on day 3 and 0.7% on
day 7; Ax-hp21-infected cells, 3.6% on day 3 and 3.1% on day 7) as
the corresponding unirradiated cells. D54MG showed a similar
trend (irradiation alone, 8.0% on day 3 and 7.4% on day 7; Ax-
mock infection plus irradiation, 12.0% on day 3 and 9.0% on day 7;
Ax-hp16 infection plus irradiation, 4.4% on day 3 and 1.3% on day
7) (Figure 3B).
As shown in Figure 3C, irradiated noninfected or Ax-mock-
infected U251MG cells were identified as scattered clusters of
fluorescent staining, suggesting that the death of these cells was
due to apoptosis. In contrast, Ax-hp16-infected U251MG cells did
not emit fluorescent signals even after irradiation. p21 transfection
caused a similar fluorescent staining in irradiated cells (Figure 3C).
Therefore, it is unlikely that the cell death of irradiated Ax-hp16-
or Ax-hp21-infected U251MG cells during the first 7 days after
irradiation was due to apoptosis.
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UKTo confirm these interpretations, the chromatin structure was
analysed using PFGE (Figure 3D). We investigated the cleavage of
chromatin by examining the formation of 50/300-kb fragments,
which are generated during the early stages of apoptosis and can
be identified by PFGE (Khodarev et al, 1998; Hwang et al, 2000;
Cipriani et al, 2001). The 50/300-kb fragments were formed in
irradiated noninfected and Ax-mock-infected U251MG cells, but
not in nonirradiated U251MG cells. Ax-hp16-infected U251MG
cells did not form 50/300-kb fragments, with or without
irradiation. These results support our hypothesis that cell death
of Ax-hp16-infected U251MG cells following irradiation is not due
to apoptosis.
Nuclear morphology
To determine the nature of the radiation-induced cell death of
the Ax-hp16- and Ax-hp21-infected cells, microscopic analysis
using Giemsa staining was performed to measure the level
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Figure 1 Effect of Ax-hp16 or Ax-hp21 infection on cell survival or cell viability in p16- or p21-null human glioma cell lines with or without irradiation. At 1
day after irradiation, U251MG cells (p16-null, p21-null, p53-mut) were infected with adenovirus vector at 5 MOI, and D54MG cells (p16-null, p53-wild)
were infected at 10 MOI. (A) U251MG, Ax-mock or Ax-hp16 infection; (B) D54MG, Ax-mock or Ax-hp16 infection; and (C) U251MG, Ax-mock or Ax-
hp21 infection show cell survival determined by clonogenic assays. (D) U251MG, Ax-mock or Ax-hp16 infection and (E) D54MG, Ax-mock or Ax-hp16
infection show cell viability determined using Trypan blue exclusion. The results of cell viability assays are shown as the mean number of cells at each point,
with standard deviation of three wells. Statistical significance: *Po0.05, compared with cells other than irradiated Ax-hp16-infected cells.
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UKof abnormal nucleus changes (budding and micro-, bi- and
multinucleation). The morphological appearance of these nuclear
changes is shown in Figure 4C, D and E.
Figure 4A shows the frequency of cells with abnormal
nucleus per 1000 uninucleated cells treated with noninfection,
Ax-mock-, Ax-hp16- or Ax-hp21 infection, with or without
irradiation, 7 days after irradiation. Irradiation alone and
Ax-mock infection plus irradiation resulted in a slight
increase in this frequency (uninfection, 64 budded, 75 micro-,
83 bi-, and 69 multinucleations; Ax-mock infection, 68 budded,
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Figure 2 Effect of p16 transduction on cell-cycle of U251MG and D54MG cells. U251MG (upper) and D54MG cells (lower), nonirradiated or irradiated
at a dose of 4Gy, noninfected or infected with Ax-hp16 or Ax-mock, were cultured for 5 days, and the cell-cycle was analysed by flow cytometry. Data are
presented as a histogram, with cell number (Y-axis) plotted against DNA content (X-axis). The first peak contains the cells with diploid DNA at G0/G1. The
cells in the second peak with double PI-fluorescence intensity are tetraploid at G2/M. The area between the two peaks contains the cells in the S phase.
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UK50 micro-, 54 bi-, and 100 multinucleations), compared to
unirradiated uninfected or Ax-mock-infected cells. As expected,
Ax-hp16 or Ax-hp21 infection alone modestly increased the
frequency of cells with an abnormal nucleus, especially for
bi- and multinucleation (Ax-hp16, 116 budded, 90 micro-,
207 bi-, and 90 multinucleations; Ax-hp21 infection, 97 budded,
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Figure 3 Apoptosis assessed by the TUNEL assay and PFGE. TUNEL assay was used for the morphological detection of apoptotic changes. U251MG or
D54MG cells, nonirradiated or irradiated at a dose of 4Gy, noninfected or infected with Ax-hp16, Ax-hp21 or Ax-mock 1 day after irradiation, were
cultured for 2 or 6 days, and were stained according to the manufacturer’s instructions after fixation with 4% formaldehyde. The AI was defined as the
percentage of TUNEL-positive U251 (A) or D54MG cells (B). (C) TUNEL signals were detected by fluorescence microscopy in the nuclei of some
irradiated uninfected or Ax-mock-infected U251MG cells (arrows). (D) The chromatin structure was analysed using PFGE. U251MG cells were treated as
described in the TUNEL assay, and, 5 days after infection, cells were embedded in agarose gel and subjected to PFGE. The 50/300-kb fragments, which are
generated during the early stage of apoptosis, were formed in irradiated noninfected and Ax-mock-infected U251MG cells. The sizes of the DNA fragments
are indicated on the left.
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UK108 micro-, 152 bi-, and 21 multinucleations), and 4-Gy irradia-
tion of Ax-hp16- or Ax-hp21-infected cells substantially
enhanced this frequency (Ax-hp16, 128 budded, 128 micro-,
398 bi-, and 214 multinucleations; Ax-hp21 infection, 158 budded,
227 micro-, 227 bi-, and 99 multinucleations), compared with
the corresponding controls (Figure 4C, D). D54MG cells
showed a similar trend (Figure 4B, E). These increases in the
frequency of cells with an abnormal nucleus are consistent
with increased abnormal nucleus formation resulting from the
combined treatment of Ax-hp16 or Ax-hp21 infection plus
irradiation.
DISCUSSION
The inactivation of p16 function has been linked to the
development of malignant gliomas, and recent investigations
have provided an insight into the manner in which this
inactivation may contribute to cell proliferation (Nobori et al,
1994; Fueyo et al, 1996; Hama et al, 1997, 1998; Costanzi-Strauss
et al, 1998). Previous findings indicate that p16-dependent
downmodulation of pRb levels in the presence of overexpressed
wild-type p53 causes apoptosis only in tumour cells, whereas
normal cells arrest in G1 (Sandig et al, 1997). Kawabe et al (2000)
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Figure 4 Effect of p16 or p21 transduction with or without irradiation on nuclear morphologic changes. U251MG or D54MG cells were treated as
described in the TUNEL assay, and nuclear morphologic changes in these treated cells were evaluated using Giemsa staining 7 days after irradiation. The
frequency of abnormal nuclei (including nuclear budding, micronucleation, binucleation and multinucleation) in U251MG (A) or D54MG cells (B)i s
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(one arrow) and nuclear budding (double arrows) in irradiated Ax-hp16-infected U251MG cells, and (E) micronucleation (one arrow), nuclear budding (two
arrows) and multinucleation (triple arrows) in irradiated Ax-hp16-infected D54MG cells.
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UKdemonstrated, by clonogenic survival assay, that adenovirus-
mediated p16 gene expression enhanced the radiosensitivity of
non-small-cell lung cancer cells, depending on the endogenous
wild-type p53 expression of the cell line. It is well established that
radiation sensitivity varies with the population of the cell-cycle,
and that cells at the M-phase and late G1 to the early S phase have
great sensitivity (Terasima and Tolmach, 1963; Okada, 1970). Here,
we assessed the ability of Ax-hp16 to enhance radiosensitivity in
human glioma cell lines that lack p16, but have either wt-p53 or
mut-p53.
The clonogenic survival assays indicated that the radiosensiti-
vity of D54MG cells, which have wt-p53, was substantially
increased by Ax-hp16 infection, as reported previously
(Figure 1B). However, contrary to this previous report, the
radiosensitivity of U251MG cells, which do not have functional
p53, was also increased by Ax-hp16 infection (Figure 1A). As
indicated by trypan blue exclusion test, U251MG and D54MG
cells exhibited reduced viability after irradiation in combination
with p16 gene replacement (Figure 1D–E). The results indicate
that Ax-hp16 infection increased cell death in a p53-indepen-
dent manner.
Based on these results, we doubt that the effect of Ax-hp16
infection on radiosensitivity was induced by the direct effect of p16
or by G1 arrest. Therefore, we used a clonogenic assay to assess the
effects on the radiosensitivity of an adenovirus vector expressing
another G1–S regulatory factor, p21. The results show that Ax-
hp21 had the same effect as Ax-hp16 (Figure 1C). Moreover, we
examined cell-cycle status using flow cytometry (Figure 2).
Radiation alone produced G1 arrest in D54MG cells and G2-M
arrest in U251MG cells. The observed difference in cell-cycle
progression between the two cell lines after irradiation may be due
to the difference in their p53 status, and is consistent with previous
findings obtained using the same cell lines (Ostruszka and
Shewach, 2000). However, Ax-hp16-infected U251MG and
D54MG cells were arrested in the G1 phase during the 6 days
following irradiation, suggesting that the induction of G1 arrest
following irradiation increases the radiosensitivity of these cells.
Kawabe et al (2000) reported that p16 gene transfer enhanced
apoptotic cell death for cells that have wt-p53, but not for p53-
mutated or p53-deleted cells. The present findings indicate that
p16 enhanced radiosensitivity via increased cell death, and that
this enhancement did not depend on p53 status. We examined the
underlying mechanism of this phenomenon using the TUNEL
assay, and demonstrated that radiation-induced cell death of
noninfected or Ax-mock-infected U251MG or D54MG cells was
due to apoptosis, whereas we found that radiation-induced cell
death of Ax-hp16-infected cells was not likely to be due to
apoptosis. We also performed an electron microscopic assay, and
detected apoptosis in noninfected U251MG cells, but not in Ax-
hp16-infected U251 MG cells after irradiation (data not shown).
The present results of PFGE and electron microscopic assay
support our hypothesis that the cell death of irradiated Ax-hp16-
infected cells was not due to apoptosis, suggesting that a different
biochemical pathway or triggering mechanisms is involved in this
mode of cell death.
Questions are raised by the present observations regarding the
mechanism, whereby the irradiated Ax-hp16-infected cells ex-
hibited cell-cycle arrest at the G1 phase (as indicated by flow
cytometry) and the mechanism of cell death. The cellular roles of
endogenous p16 are relatively poorly understood, but it is clear
that its role is not limited to G1/S arrest. In HeLa cells, G2 delay
correlates with elevated p16 levels, and loss of p16 expression
results in loss of UVC-induced cell-cycle delay (Wang et al, 1996).
Milligan et al (1998) reported that p16 acts specifically via its
binding to cdk4 to produce G2 delay responses following UVC
irradiation in melanoma cell lines. Moreover, p16 is found not only
in the nucleus but also in the cytoplasm, especially in cancer cells
(Sano et al, 1998; Chen et al, 1999), and plays an important role in
the regulation of vascular endothelial growth factor (VEGF)
expression and cell senescence (Harada et al, 1999).
It has been suggested that cancer cells can escape from G1/S
arrest induced by p16, RB loss and Cyclin D1 amplification, via
mechanisms that can over-ride the braking effect (Sherr et al,
1996). If there is a concomitant rapid exit from G2/S arrest induced
by p16, there is no accumulation of tetraploid cells. In malignant
cells, this exit can occur by abnormal nucleation, a term that
includes not only nuclear budding/micronucleation and simple
unequal nuclear division but also multipolar mitosis, repeated
karyokinesis with acytokinesis and all divisions not associated
with normal mitosis. The formation of these structures is not
detectable by flow cytometry, because this method evaluates bare
nuclei (Bhattathiri, 2001). Figure 2 indicates that the distribution
of values around 2N and 4N is wider in the Ax-hp16-infected cells
(both irradiated and nonirradiated), compared to the noninfected
and Ax-mock-infected cells, a finding consistent with abnormal
nucleation. Therefore, we used Giemsa staining to assay the
induction of micronucleation, nuclear budding, binucleation and
multinucleation individually in U251MG and D54MG cells 7 days
after irradiation, with or without adenovirus infection (Figure 4).
In uninfected and Ax-mock-infected cells, there was an increase
in cells with the above abnormalities, especially micro- and
budded nucleation. Also, in Ax-hp16- and Ax-hp21-infected cells,
there was an increase in cells with the above abnormalities,
especially bi- and multinucleation. In unirradiated Ax-hp16- and
Ax-hp21-infected U251MG cells, there was an increase in cells with
the above abnormalities, especially bi- and multinucleation, but
there was little change in unirradiated D54MG cells.
The situation is likely to be different when p16 and radiation are
combined, with radiation inducing rapid proliferation and p16
facilitating rapid exit from G2/S arrest by abnormal nucleation.
This abolishes apoptosis induced by G2/S arrest, yet promotes cell
death by abnormal nucleation. The interaction of radiation and
p16 in the morphological changes of abnormal nucleation has been
reported. In skin cells, increased p16 expression with cytoplasmic
predominance after UV irradiation correlates with the develop-
ment of bi-, multi- and micronucleated cells (Milligan et al, 1998;
Pavey et al, 1999). These observations suggest an unknown
interaction between radiation and p16 in cytoplasm/membranes,
which decreases cytokinesis and promotes abnormal nucleation.
Fueyo et al (1996) have shown that adenovirus-mediated p16
gene transfection alone significantly inhibits cell growth, a finding
not obtained in the present study; Ax-hp16-infected cells used in
the present study lost cell viability, as indicated in Figure 1D. This
inhibition may be due to the induction of abnormal nucleated
nonclonogenic cells. Obviously, the rates of survival and formation
of multinucleated cells are likely to be higher in glioblastomas
(Meyer-Puttlitz et al, 1997). Abnormal nucleation can also explain
why apoptosis observed with radiation alone was absent when p16
transfection and radiation were combined. Obviously, p16 expres-
sion prevented radiation-induced apoptosis by promoting abnor-
mal nucleation, thereby leading to cell death via this alternative
mechanism. The situation can be viewed as radiation enhancing
the effect of p16, resulting in an increase of radiation-induced cell
death.
With p21, similar effects are possible, because p21 expression
has also been found to be related to multinucleation (Okahashi
et al, 2001). Mutinuclear osteoclast-like cell formation from
osteoblasts is related to the upregulation of p21, with the majority
of cells remaining at the G0/G1 phase (Tanaka et al, 2000). The
integrity of p21 within centrosomes is related to apoptosis,
multinucleation and normal mitotic progression (Li et al, 1999).
It has been reported that, in MCF-7 cells, pacllitaxel induced the
accumulation of p21 in cells with G2/M DNA content; this
corresponds to cells in abnormal mitosis or an interphase-like
state with multiple nuclei, the increase in p21 being subsequent to
mitotic arrest and associated with exit from abnormal mitosis
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British Journal of Cancer (2003) 89(9), 1802–1811 & 2003 Cancer Research UKleading to the formation of cells with micronuclei (Barboule et al,
1997). It is possible that radiation also affects p21 localised in the
centrosome complex, resulting in bi- or multinucleation.
Cell survival (assessed by clonogenic assay) markedly decreased
in irradiated Ax-hp16-infected U251MG and D54MG cells, whereas
cell viability (determined by trypan blue exclusion) only slightly
decreased in the same cell lines; thus, the results of these two
analyses are apparently not consistent. Physically dead cells are
stained by trypan blue, but the formation of cellular fragmentation
or cellular debris can occur over a period of several days,
depending on the type of cell death; thus, trypan blue-positive
(dead) cells are thought to reflect cells that died within a few days.
On the other hand, abnormal nucleated cells are thought to be
clonogenically dead, but not physically dead, and can synthesise
DNA and continue to divide several times before death after
irradiation (Bhattathiri, 2001). Unirradiated Ax-hp16-infected
U251MG cells exhibited a modest increase in the proportion of
abnormally nucleated cells, and 4-Gy irradiation of Ax-hp16-
infected cells substantially enhanced this proportion (Figure 4A).
After irradiation of Ax-hp16-infected D54MG cells, the frequency
of abnormal nucleated cells increased (Figure 4B). Abnormal
nucleated cells may not be completely detected by trypan blue
analysis, but they are not clonogenic; thus, it is thought that the
discrepancy was between cell viability and clonogenic assay.
A comparison between mock-infected and p16-infected D54MG
cells (Figure 1E) shows that cell viability decreased identically for
these cell populations until day 8 after irradiation. Teramoto et al
(1995) examined whether E1-, E3-deleted adenovirus vectors affect
the cell viability of human airway cells in primary culture, using
trypan blue exclusion, and demonstrated that, as the MOI of
adenovirus vectors is increased (to achieve effective gene transfer),
the viability of infected cells is reduced concomitantly via
apoptotic change. This reduced viability persisted for 5–7 days
after vector administration. Tang et al (1997) demonstrated that
irradiating cells at doses of 2–40Gy prior to transduction could
amplify recombinant adenoviral transgene products in a cell-type-
specific manner. The apoptotic index of Ax-mock-infected D54MG
cells increased, compared with uninfected cells, on days 3 and 7,
with or without irradiation (Figure 3), but this trend was not
exhibited by U251MG cells. One of the differences between
U251MG and D54MG cells is p53 status; that is, p53 of U251MG
is mutant, whereas that of D54MG is wild type. Therefore, it is
possible that, in D54MG cells (but not in U251MG cells),
irradiation amplified the recombinant adenoviral transgene
products, activated a p53-dependent apoptotic pathway and
increased apoptotic cell death, resulting in the reduction of cell
viability, especially during the first 8 days after infection.
In the present study, continuous p16 gene expression had a
significant cell killing effect after irradiation, but transient
expression had little effect. Establishment of a promising strategy
for gene therapy treatment of human malignant glioma patients
using irradiation plus p16 gene expression requires continuous
transgene expression. The adenoviral vectors used here are
effective for gene transfer to many tissues, and confer high levels
of expression of recombinant genes. However, the use of first-
generation vectors usually results in transient transgene expression
only, because of the development of a cellular immune response
triggered by viral proteins expressed by adenovirus genes, the dose
of virus administered, the promoter chosen to drive expression of
the recombinant gene, innate immune mechanisms and direct
cytotoxicity caused by the expression of viral genes (Morral et al,
1999). Future studies of prolongation of in vivo expression of
adenovirally administered transgenes with minimised direct
cytotoxicity may clarify the number of functions mediated by
p16 and p21 after irradiation (eg, modulation of cytokinesis or
karyokinesis) and contribute to gene therapy treatment of human
malignant glioma patients.
To confirm whether the effect of Ax-hp16 infection plus
irradiation was specific for human glioma cell lines, we also
performed the clonogenic assay for other p16-null human cancer
cell lines infected with Ax-hp16: the non-small-cell lung cancer cell
line A549 (p21, undetectable protein expression; p53, wild type),
and the gastric cancer cell line MKN45 (p21 and p53, wild type).
The results indicate that the cell survival of these cancer cell lines
was substantially decreased by Ax-hp16 infection (data not shown)
(Kawabe et al, 2000; Yokozaki, 2000). These findings suggest that
adenovirus-mediated p16 gene transfer increased radiosensitivity
via nonapoptotic cell killing in these other human cancer cell lines.
The present results demonstrate that p16 gene transfer following
radiation results in cell death. The modulation of the cell death
response by intervention in a specific signal transduction pathway
between radiation and p16 in cytoplasm/membranes, perturbing
cytokinesis and promoting abnormal nucleation, may enhance the
cytotoxic effect of radiation, thus improving the therapeutic ratio.
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